Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones

M. Zuin, M. L. Petroni, G. Grandinetti, A. Crosignani, E. Bertolini, P. M. Battezzati, M. Podda

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To study the effects of different bile acids on biliary lipids in obese patients with radiolucent gallstones, 12 subjects were given chenodeoxycholic acid (CDCA) at a dose of 15 mg/kg/day, ursodeoxycholic acid (UDCA) at a dose of 15 mg/kg/day, and an equimolar combination of the two (7.5 + 7.5 mg/kg/day) in accordance with a double-blind crossover design. Mean molar percentage of cholesterol and cholesterol saturation index corrected for urso-rich bile (CSI) decreased significantly with all three treatments, but the combination was more effective in decreasing the CSI than either of the two bile acids given alone (p 0.05). Bile became desaturated in 10 of 12 patients receiving the combination, in 4 of 12 receiving CDCA, and 3 of 12 receiving UDCA alone. Combination treatment was well tolerated since mild diarrhea and slight increase in transaminases were observed only in a few patients. We conclude that the combined administration of CDCA and UDCA in equimolar doses is the treatment of choice for dissolution of gallstones in obese patients.

Original languageEnglish
Pages (from-to)257-262
Number of pages6
JournalScandinavian Journal of Gastroenterology
Volume26
Issue number3
DOIs
Publication statusPublished - 1991

Fingerprint

Chenodeoxycholic Acid
Ursodeoxycholic Acid
Gallstones
Lipids
Bile Acids and Salts
Bile
Cholesterol
Transaminases
Cross-Over Studies
Diarrhea
Therapeutics

Keywords

  • Bile
  • Bile acids
  • Chenodeoxycholic acid
  • Cholelithiasis
  • Obesity
  • Ursodeoxycholic acid

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones. / Zuin, M.; Petroni, M. L.; Grandinetti, G.; Crosignani, A.; Bertolini, E.; Battezzati, P. M.; Podda, M.

In: Scandinavian Journal of Gastroenterology, Vol. 26, No. 3, 1991, p. 257-262.

Research output: Contribution to journalArticle

Zuin, M. ; Petroni, M. L. ; Grandinetti, G. ; Crosignani, A. ; Bertolini, E. ; Battezzati, P. M. ; Podda, M. / Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones. In: Scandinavian Journal of Gastroenterology. 1991 ; Vol. 26, No. 3. pp. 257-262.
@article{e69568b791d548798e8be492782264fd,
title = "Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones",
abstract = "To study the effects of different bile acids on biliary lipids in obese patients with radiolucent gallstones, 12 subjects were given chenodeoxycholic acid (CDCA) at a dose of 15 mg/kg/day, ursodeoxycholic acid (UDCA) at a dose of 15 mg/kg/day, and an equimolar combination of the two (7.5 + 7.5 mg/kg/day) in accordance with a double-blind crossover design. Mean molar percentage of cholesterol and cholesterol saturation index corrected for urso-rich bile (CSI) decreased significantly with all three treatments, but the combination was more effective in decreasing the CSI than either of the two bile acids given alone (p 0.05). Bile became desaturated in 10 of 12 patients receiving the combination, in 4 of 12 receiving CDCA, and 3 of 12 receiving UDCA alone. Combination treatment was well tolerated since mild diarrhea and slight increase in transaminases were observed only in a few patients. We conclude that the combined administration of CDCA and UDCA in equimolar doses is the treatment of choice for dissolution of gallstones in obese patients.",
keywords = "Bile, Bile acids, Chenodeoxycholic acid, Cholelithiasis, Obesity, Ursodeoxycholic acid",
author = "M. Zuin and Petroni, {M. L.} and G. Grandinetti and A. Crosignani and E. Bertolini and Battezzati, {P. M.} and M. Podda",
year = "1991",
doi = "10.3109/00365529109025039",
language = "English",
volume = "26",
pages = "257--262",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones

AU - Zuin, M.

AU - Petroni, M. L.

AU - Grandinetti, G.

AU - Crosignani, A.

AU - Bertolini, E.

AU - Battezzati, P. M.

AU - Podda, M.

PY - 1991

Y1 - 1991

N2 - To study the effects of different bile acids on biliary lipids in obese patients with radiolucent gallstones, 12 subjects were given chenodeoxycholic acid (CDCA) at a dose of 15 mg/kg/day, ursodeoxycholic acid (UDCA) at a dose of 15 mg/kg/day, and an equimolar combination of the two (7.5 + 7.5 mg/kg/day) in accordance with a double-blind crossover design. Mean molar percentage of cholesterol and cholesterol saturation index corrected for urso-rich bile (CSI) decreased significantly with all three treatments, but the combination was more effective in decreasing the CSI than either of the two bile acids given alone (p 0.05). Bile became desaturated in 10 of 12 patients receiving the combination, in 4 of 12 receiving CDCA, and 3 of 12 receiving UDCA alone. Combination treatment was well tolerated since mild diarrhea and slight increase in transaminases were observed only in a few patients. We conclude that the combined administration of CDCA and UDCA in equimolar doses is the treatment of choice for dissolution of gallstones in obese patients.

AB - To study the effects of different bile acids on biliary lipids in obese patients with radiolucent gallstones, 12 subjects were given chenodeoxycholic acid (CDCA) at a dose of 15 mg/kg/day, ursodeoxycholic acid (UDCA) at a dose of 15 mg/kg/day, and an equimolar combination of the two (7.5 + 7.5 mg/kg/day) in accordance with a double-blind crossover design. Mean molar percentage of cholesterol and cholesterol saturation index corrected for urso-rich bile (CSI) decreased significantly with all three treatments, but the combination was more effective in decreasing the CSI than either of the two bile acids given alone (p 0.05). Bile became desaturated in 10 of 12 patients receiving the combination, in 4 of 12 receiving CDCA, and 3 of 12 receiving UDCA alone. Combination treatment was well tolerated since mild diarrhea and slight increase in transaminases were observed only in a few patients. We conclude that the combined administration of CDCA and UDCA in equimolar doses is the treatment of choice for dissolution of gallstones in obese patients.

KW - Bile

KW - Bile acids

KW - Chenodeoxycholic acid

KW - Cholelithiasis

KW - Obesity

KW - Ursodeoxycholic acid

UR - http://www.scopus.com/inward/record.url?scp=0026036171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026036171&partnerID=8YFLogxK

U2 - 10.3109/00365529109025039

DO - 10.3109/00365529109025039

M3 - Article

VL - 26

SP - 257

EP - 262

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 3

ER -